Ballast Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.2K Sell
926
-8,078
-90% -$774K 0.02% 174
2025
Q4
$865K Sell
9,004
-35
-0.4% -$3.4K 0.24% 54
2025
Q3
$861K Buy
9,039
+100
+1% +$9.19K 0.24% 56
2025
Q2
$779K Buy
8,939
+3,788
+74% +$321K 0.23% 58
2025
Q1
$463K Sell
5,151
-52
-1% -$4.65K 0.15% 74
2024
Q4
$416K Sell
5,203
-258
-5% -$22.3K 0.13% 77
2024
Q3
$492K Hold
5,461
0.15% 74
2024
Q2
$430K Sell
5,461
-2
-0% -$164 0.14% 80
2024
Q1
$476K Sell
5,463
-19
-0.3% -$1.62K 0.16% 73
2023
Q4
$452K Sell
5,482
-635
-10% -$48.4K 0.17% 75
2023
Q3
$479K Sell
6,117
-1,415
-19% -$118K 0.19% 68
2023
Q2
$664K Sell
7,532
-118
-2% -$10.2K 0.25% 48
2023
Q1
$617K Sell
7,650
-1,398
-15% -$114K 0.25% 44
2022
Q4
$703K Sell
9,048
-90
-1% -$7.29K 0.31% 43
2022
Q3
$738K Sell
9,138
-768
-8% -$69K 0.35% 41
2022
Q2
$889K Buy
9,906
+3
+0% +$304 0.4% 36
2022
Q1
$1.1M Sell
9,903
-40
-0.4% -$4.23K 0.43% 35
2021
Q4
$1.03M Hold
9,943
0.39% 36
2021
Q3
$1.25M Sell
9,943
-10
-0.1% -$1.29K 0.52% 32
2021
Q2
$1.24M Buy
9,953
+4
+0% +$502 0.52% 31
2021
Q1
$1.18M Hold
9,949
0.54% 31
2020
Q4
$1.17M Sell
9,949
-335
-3% -$36.9K 0.6% 29
2020
Q3
$1.07M Sell
10,284
-96
-0.9% -$9.64K 0.67% 27
2020
Q2
$952K Buy
10,380
+1,312
+14% +$126K 0.68% 27
2020
Q1
$818K Buy
9,068
+374
+4% +$39.8K 0.77% 23
2019
Q4
$986K Buy
+8,694
New +$954K 0.73% 26

Other funds holding MDT

Ballast Advisors's MDT Position: Q1 2026 in Review

Ballast Advisors reduced its Medtronic (MDT) stake by 90% in Q1 2026, selling an estimated $774K and leaving 926 shares worth $80.2K. The position accounts for 0.02% of the portfolio, ranked #174.

Ballast Advisors first reported a position in MDT in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.25M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Ballast Advisors held 926 shares of Medtronic worth $80.2K as of Q1 2026.
  • Ballast Advisors sold 8,078 Medtronic shares in Q1 2026, an estimated $774K.
  • Medtronic made up 0.02% of Ballast Advisors's portfolio in Q1 2026, its #174 holding.
  • Ballast Advisors first reported a position in Medtronic in Q4 2019 and has held it in 26 quarters since.
  • Ballast Advisors's Medtronic position peaked at $1.25M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Ballast Advisors's 13F filing for Q1 2026, filed 13 May 2026.